The original version of this story was published on HuffPost at an earlier date.
Assessment HOMA as a predictor for new onset diabetes mellitus and diabetic complications in non-diabetic adults: a KoGES prospective cohort study
Available from: Sanal-Hayes NEM, McLaughlin M, Hayes LD, Mair JL, Ormerod J, Carless D, et al
Multi-agonists (triple G) aim to harmonize GLP-1 , GIP , and possibly glucagon pathways for optimized weight/metabolic outcomes
Returning to an early quote: Yes, you said it very well and are spot on
Your doctor can adjust your dose and monitor your progress regularly, ensuring safe and effective management of hyperphagia and weight while maintaining your overall health